Bladder Cancer Video Channel
Explore the latest insights and summaries from experts in Bladder Cancer.
Therapeutic Agents
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,023 views
- April 16, 2024
- 11
ecancer
Emerging Horizons: Next-Generation Therapies in Localized Bladder Cancer Care
FEATURING
Carmen Mir
- 60 views
- April 25, 2024
University of Illinois Cancer Center
Recent Advances in Molecular-Guided Treatment of GU Malignancies
FEATURING
Natalie Reizine
- 235 views
- May 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "AURA Trial Survival Data - Avelumab as Neoadjuvant Therapy in MIUC"
FEATURING
Jeremy Blanc
- 173 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"
FEATURING
Erika Hamilton
- 1,585 views
- June 18, 2024
- 7
UCSF School of Medicine
Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer
FEATURING
Vadim Koshkin
- 264 views
- June 20, 2024
- 2
ecancer
ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"
FEATURING
Antonio Cigliola
- 46 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 540 views
- July 5, 2024
- 1
Nebraska Oncology Society
ASCO® 2024 Review: Metastatic Bladder Cancer Treated with EV + Pembro & Impact of PRO From EV-302
FEATURING
Nataliya Mar
- 58 views
- July 30, 2024
Integrity CE
Updates in the Treatment and Management of Bladder Cancer
FEATURING
Matthew Galsky,
Brendan Guercio
- 299 views
- August 2, 2024
- 1
Arlene Siefker-Radtke
Emerging Novel Agents in Metastatic Urothelial Cancer
- 87 views
- August 29, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Key RCC/Bladder/Testicular GU Updates From ASCO® 2024
FEATURING
Jonathan Trujillo
- 53 views
- September 4, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Practice-Changing Trials for Patients With Localized MIBC - NIAGARA and AMBASSADOR
FEATURING
Petros Grivas
- 260 views
- September 20, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Key Trial Results in Advanced Bladder Cancer Treatment
FEATURING
Guru Sonpavde
- 158 views
- September 24, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Novel Agents and Promising Combinations in mRCC and mUC
FEATURING
Begoña Pérez-Valderrama
- 73 views
- October 8, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Developmental Therapeutics Highlights
FEATURING
Guru Sonpavde
- 277 views
- October 25, 2024
- 3
Jennifer Linehan
WCET 2024 Insights: UTUC - Ablative Therapy Are We There Yet
- 162 views
- November 22, 2024
- 1
Total Health
Emerging Trends in Localized Bladder Cancer in 2024
FEATURING
Nikhil Gopal
- 179 views
- March 5, 2024
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
FEATURING
Thomas Powles,
Brian Rini
- 1,521 views
- March 7, 2024
- 6
AdventHealth
FDA Approval of Gemcitabine-Cisplatin + Nivo as 1L Therapy for Advanced Urothelial Carcinoma
FEATURING
Guru Sonpavde
- 274 views
- March 11, 2024
- 1
Scripps Health
Sequencing 2L & Later Line Therapies in Metastatic Urothelial Carcinoma
FEATURING
Petros Grivas
- 159 views
- March 14, 2024
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
FEATURING
Young Chae
- 1,206 views
- April 19, 2024
- 5
Daniel Shapiro
Non-Extirpative Management of Upper Tract Urothelial Carcinoma
- 19 views
- November 4, 2024
Oncology 2024 Year in Review
Year in Review 2024 - Bladder Cancer
FEATURING
Guru Sonpavde
- 180 views
- December 2, 2024
- 2
Moffitt Cancer Center
Intravesical TIL for Bladder Cancer
FEATURING
Michael Poch
- 166 views
- December 10, 2024
- 2